Due to the lower enzymatic activity of PKM2 as compared with that of PKM1, the major amount of glucose present in the cell remains as glycolytic intermediates which provide building blocks, such as amino acids, nucleotides, and fatty acids, to the highly proliferating cancer cells [8]. The gene discussed is PKM; the disease is cancer.